Form 4: Henry Schein Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Henry Schein Director Philip A. Laskawy sold 2,844 shares of common stock for $80.36 per share under a pre-arranged trading plan.
Summary
- Philip A. Laskawy, a Director of Henry Schein, Inc. (HSIC), reported a transaction involving the company's common stock.
- The transaction occurred on March 5, 2026, and involved the disposition of 2,844 shares.
- The shares were sold at a price of $80.36 per share.
- Following this transaction, Philip A. Laskawy beneficially owns 21,961 shares of Henry Schein common stock.
- The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine insider transaction under a pre-arranged 10b5-1 plan, which typically does not signal a significant change in company outlook or management confidence.
Positives
- The transaction was conducted under a Rule 10b5-1(c) plan, indicating it was pre-scheduled and not based on new, non-public information, which can reduce concerns about opportunistic insider selling.
Negatives
- A director selling shares, even under a 10b5-1 plan, can sometimes be perceived by investors as a lack of confidence in the company's near-term prospects, though this is often a routine liquidity or diversification event.
Future Outlook
This Form 4 filing is a report of an insider transaction and does not contain any forward-looking statements or guidance regarding the company's future performance.
Industry Context
StockSavvy.ai notes that insider transactions, particularly those by directors, are closely watched by the market as they can offer insights into management's perspective on the company's valuation and future. However, sales executed under a Rule 10b5-1 plan are generally viewed as less indicative of a change in sentiment compared to open market discretionary sales, as these plans are established in advance.
Stakeholder Impact
- Shareholders may note the director's sale, but the pre-planned nature under a 10b5-1 plan suggests it is not based on new, non-public information, potentially mitigating negative sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/05/2026 | Date of transaction (disposition of shares) |
| 03/06/2026 | Date the Form 4 was signed and filed |
Recommendation
holdA single insider sale, particularly one executed under a Rule 10b5-1 plan, is generally not a strong enough signal on its own to warrant a change in investment recommendation. These sales are often for personal financial planning, diversification, or liquidity purposes and are pre-scheduled, reducing the likelihood of being based on new, material non-public information. Investors should consider this transaction in the broader context of the company's financial performance and market conditions.
Keywords
Henry Schein, HSIC, Insider Sale, Form 4, Director Transaction, Stock Sale, Philip A. Laskawy, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.